Cellectis (CLLS) Revenue: 2015-2023
Historic Revenue for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to $155,000.
- Cellectis' Revenue fell 11.43% to $155,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $16.5 million, marking a year-over-year increase of 23.02%. This contributed to the annual value of $25.7 million for FY2022, which is 33.35% down from last year.
- Per Cellectis' latest filing, its Revenue stood at $155,000 for Q3 2023, which was down 12.92% from $178,000 recorded in Q2 2023.
- Over the past 5 years, Cellectis' Revenue peaked at $50.1 million during Q1 2020, and registered a low of $139,000 during Q1 2023.
- Its 3-year average for Revenue is $6.8 million, with a median of $1.7 million in 2022.
- As far as peak fluctuations go, Cellectis' Revenue skyrocketed by 4,738.61% in 2020, and later tumbled by 97.89% in 2022.
- Cellectis' Revenue (Quarterly) stood at $4.4 million in 2019, then skyrocketed by 208.59% to $13.6 million in 2020, then fell by 24.82% to $10.3 million in 2021, then skyrocketed by 56.15% to $16.0 million in 2022, then dropped by 11.43% to $155,000 in 2023.
- Its Revenue stands at $155,000 for Q3 2023, versus $178,000 for Q2 2023 and $139,000 for Q1 2023.